This CTD dossier owner and manufacturer, operating for over four decades in Southeast Asia, focuses on providing a wide range of healthcare solutions. Their product portfolio encompasses Rx (prescription) and OTC (over-the-counter) pharmaceuticals, medical devices, and nutraceuticals. Key therapy areas include dermatology, general health, and infection control. The company manufactures various dosage forms, including solids, liquids, and injectables. Their production facilities adhere to stringent EU and US GMP standards, demonstrating their commitment to quality and safety. The company's online platform facilitates convenient access to its products and information. They also offer toll manufacturing services and act as marketing authorization holders for other companies.

​Established in 1954, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 15 countries and regions. With a workforce of approximately 1,000 employees, it operates GMP-certified facilities in South Korea, producing tablets, capsules, and injectable formulations. As a GMP manufacturer, it holds certifications such as PIC/S GMP and EU GMP compliance. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

​Established in 1954, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 15 countries and regions. With a workforce of approximately 1,000 employees, it operates GMP-certified facilities in South Korea, producing tablets, capsules, and injectable formulations. As a GMP manufacturer, it holds certifications such as PIC/S GMP and EU GMP compliance. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​